nodes	percent_of_prediction	percent_of_DWPC	metapath
Ofloxacin—TOP2A—Teniposide—lymphatic system cancer	0.248	0.318	CbGbCtD
Ofloxacin—TOP2A—Mitoxantrone—lymphatic system cancer	0.173	0.222	CbGbCtD
Ofloxacin—ABCC1—Mitoxantrone—lymphatic system cancer	0.0961	0.123	CbGbCtD
Ofloxacin—ABCC1—Vincristine—lymphatic system cancer	0.0662	0.0848	CbGbCtD
Ofloxacin—CYP1A2—Carmustine—lymphatic system cancer	0.0564	0.0723	CbGbCtD
Ofloxacin—ABCC2—Vincristine—lymphatic system cancer	0.049	0.0628	CbGbCtD
Ofloxacin—ABCC1—Methotrexate—lymphatic system cancer	0.0401	0.0513	CbGbCtD
Ofloxacin—ABCC2—Methotrexate—lymphatic system cancer	0.0297	0.038	CbGbCtD
Ofloxacin—SLC22A6—Methotrexate—lymphatic system cancer	0.0217	0.0278	CbGbCtD
Ofloxacin—TOP2A—Etoposide—Teniposide—lymphatic system cancer	0.00108	0.195	CbGdCrCtD
Ofloxacin—TOP2A—Podofilox—Teniposide—lymphatic system cancer	0.000825	0.149	CbGdCrCtD
Ofloxacin—TOP2A—Vindesine—Vincristine—lymphatic system cancer	0.000778	0.14	CbGdCrCtD
Ofloxacin—TOP2A—Vinorelbine—Vincristine—lymphatic system cancer	0.000491	0.0884	CbGdCrCtD
Ofloxacin—TOP2A—Cladribine—Fludarabine—lymphatic system cancer	0.000371	0.0669	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Fludarabine—lymphatic system cancer	0.000343	0.0619	CbGdCrCtD
Ofloxacin—TOP2A—Vinblastine—Vincristine—lymphatic system cancer	0.000337	0.0608	CbGdCrCtD
Ofloxacin—TOP2A—Clofarabine—Cytarabine—lymphatic system cancer	0.000324	0.0584	CbGdCrCtD
Ofloxacin—TOP2A—Gemcitabine—Cytarabine—lymphatic system cancer	0.0003	0.0541	CbGdCrCtD
Ofloxacin—TOP2A—Cytarabine—Fludarabine—lymphatic system cancer	0.000292	0.0526	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Fludarabine—lymphatic system cancer	0.000209	0.0377	CbGdCrCtD
Ofloxacin—TOP2A—Azacitidine—Cytarabine—lymphatic system cancer	0.000198	0.0356	CbGdCrCtD
Ofloxacin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00018	0.00084	CcSEcCtD
Ofloxacin—Asthenia—Fludarabine—lymphatic system cancer	0.00018	0.00084	CcSEcCtD
Ofloxacin—Rash—Teniposide—lymphatic system cancer	0.00018	0.00084	CcSEcCtD
Ofloxacin—Dermatitis—Teniposide—lymphatic system cancer	0.00018	0.000839	CcSEcCtD
Ofloxacin—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.000179	0.000836	CcSEcCtD
Ofloxacin—Headache—Teniposide—lymphatic system cancer	0.000179	0.000834	CcSEcCtD
Ofloxacin—Pruritus—Fludarabine—lymphatic system cancer	0.000177	0.000828	CcSEcCtD
Ofloxacin—Lymphadenopathy—Methotrexate—lymphatic system cancer	0.000177	0.000827	CcSEcCtD
Ofloxacin—Back pain—Mitoxantrone—lymphatic system cancer	0.000177	0.000825	CcSEcCtD
Ofloxacin—Leukopenia—Carmustine—lymphatic system cancer	0.000176	0.000821	CcSEcCtD
Ofloxacin—Anorexia—Bleomycin—lymphatic system cancer	0.000175	0.000818	CcSEcCtD
Ofloxacin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000175	0.000815	CcSEcCtD
Ofloxacin—Diabetes mellitus—Methotrexate—lymphatic system cancer	0.000174	0.000812	CcSEcCtD
Ofloxacin—Anaemia—Vincristine—lymphatic system cancer	0.000173	0.00081	CcSEcCtD
Ofloxacin—Agitation—Vincristine—lymphatic system cancer	0.000172	0.000805	CcSEcCtD
Ofloxacin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000172	0.000804	CcSEcCtD
Ofloxacin—Photosensitivity—Methotrexate—lymphatic system cancer	0.000172	0.000804	CcSEcCtD
Ofloxacin—Polyuria—Methotrexate—lymphatic system cancer	0.000172	0.000804	CcSEcCtD
Ofloxacin—Hypotension—Bleomycin—lymphatic system cancer	0.000172	0.000802	CcSEcCtD
Ofloxacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000171	0.000801	CcSEcCtD
Ofloxacin—Hypertension—Carmustine—lymphatic system cancer	0.00017	0.000792	CcSEcCtD
Ofloxacin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000169	0.000792	CcSEcCtD
Ofloxacin—Nausea—Teniposide—lymphatic system cancer	0.000169	0.000791	CcSEcCtD
Ofloxacin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000169	0.000789	CcSEcCtD
Ofloxacin—Vertigo—Vincristine—lymphatic system cancer	0.000168	0.000787	CcSEcCtD
Ofloxacin—Hepatic failure—Methotrexate—lymphatic system cancer	0.000168	0.000785	CcSEcCtD
Ofloxacin—Leukopenia—Vincristine—lymphatic system cancer	0.000168	0.000784	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.000167	0.000782	CcSEcCtD
Ofloxacin—Myalgia—Carmustine—lymphatic system cancer	0.000167	0.000781	CcSEcCtD
Ofloxacin—Chest pain—Carmustine—lymphatic system cancer	0.000167	0.000781	CcSEcCtD
Ofloxacin—Anxiety—Carmustine—lymphatic system cancer	0.000167	0.000779	CcSEcCtD
Ofloxacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000165	0.000771	CcSEcCtD
Ofloxacin—Malaise—Mitoxantrone—lymphatic system cancer	0.000165	0.000769	CcSEcCtD
Ofloxacin—Dyspnoea—Bleomycin—lymphatic system cancer	0.000164	0.000765	CcSEcCtD
Ofloxacin—Renal failure acute—Methotrexate—lymphatic system cancer	0.000164	0.000765	CcSEcCtD
Ofloxacin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.000163	0.000764	CcSEcCtD
Ofloxacin—Hypertension—Vincristine—lymphatic system cancer	0.000162	0.000756	CcSEcCtD
Ofloxacin—Confusional state—Carmustine—lymphatic system cancer	0.000162	0.000755	CcSEcCtD
Ofloxacin—Oedema—Carmustine—lymphatic system cancer	0.00016	0.000749	CcSEcCtD
Ofloxacin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.00016	0.000748	CcSEcCtD
Ofloxacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00016	0.000746	CcSEcCtD
Ofloxacin—Myalgia—Vincristine—lymphatic system cancer	0.00016	0.000746	CcSEcCtD
Ofloxacin—Visual disturbance—Methotrexate—lymphatic system cancer	0.000159	0.000745	CcSEcCtD
Ofloxacin—Cough—Mitoxantrone—lymphatic system cancer	0.000159	0.000745	CcSEcCtD
Ofloxacin—Infection—Carmustine—lymphatic system cancer	0.000159	0.000744	CcSEcCtD
Ofloxacin—Vomiting—Fludarabine—lymphatic system cancer	0.000159	0.000744	CcSEcCtD
Ofloxacin—Rash—Fludarabine—lymphatic system cancer	0.000158	0.000738	CcSEcCtD
Ofloxacin—Dermatitis—Fludarabine—lymphatic system cancer	0.000158	0.000737	CcSEcCtD
Ofloxacin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000158	0.000737	CcSEcCtD
Ofloxacin—Pain—Bleomycin—lymphatic system cancer	0.000157	0.000734	CcSEcCtD
Ofloxacin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.000157	0.000733	CcSEcCtD
Ofloxacin—Headache—Fludarabine—lymphatic system cancer	0.000157	0.000733	CcSEcCtD
Ofloxacin—Tachycardia—Carmustine—lymphatic system cancer	0.000156	0.000731	CcSEcCtD
Ofloxacin—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.000156	0.000729	CcSEcCtD
Ofloxacin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000155	0.000726	CcSEcCtD
Ofloxacin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.000155	0.000726	CcSEcCtD
Ofloxacin—Myalgia—Mitoxantrone—lymphatic system cancer	0.000155	0.000726	CcSEcCtD
Ofloxacin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000155	0.000724	CcSEcCtD
Ofloxacin—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.000154	0.00072	CcSEcCtD
Ofloxacin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000154	0.000718	CcSEcCtD
Ofloxacin—Oedema—Vincristine—lymphatic system cancer	0.000153	0.000715	CcSEcCtD
Ofloxacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000153	0.000715	CcSEcCtD
Ofloxacin—Anorexia—Carmustine—lymphatic system cancer	0.000153	0.000714	CcSEcCtD
Ofloxacin—Infection—Vincristine—lymphatic system cancer	0.000152	0.00071	CcSEcCtD
Ofloxacin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000151	0.000707	CcSEcCtD
Ofloxacin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000151	0.000706	CcSEcCtD
Ofloxacin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00015	0.000702	CcSEcCtD
Ofloxacin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00015	0.000701	CcSEcCtD
Ofloxacin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00015	0.0007	CcSEcCtD
Ofloxacin—Hypotension—Carmustine—lymphatic system cancer	0.00015	0.0007	CcSEcCtD
Ofloxacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000149	0.000696	CcSEcCtD
Ofloxacin—Oedema—Mitoxantrone—lymphatic system cancer	0.000149	0.000696	CcSEcCtD
Ofloxacin—Nausea—Fludarabine—lymphatic system cancer	0.000149	0.000695	CcSEcCtD
Ofloxacin—Infection—Mitoxantrone—lymphatic system cancer	0.000148	0.000692	CcSEcCtD
Ofloxacin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000148	0.000691	CcSEcCtD
Ofloxacin—Shock—Mitoxantrone—lymphatic system cancer	0.000147	0.000685	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.000146	0.000682	CcSEcCtD
Ofloxacin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000146	0.000682	CcSEcCtD
Ofloxacin—Urticaria—Bleomycin—lymphatic system cancer	0.000146	0.000682	CcSEcCtD
Ofloxacin—Anorexia—Vincristine—lymphatic system cancer	0.000146	0.000682	CcSEcCtD
Ofloxacin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000145	0.00068	CcSEcCtD
Ofloxacin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000145	0.000678	CcSEcCtD
Ofloxacin—Insomnia—Carmustine—lymphatic system cancer	0.000145	0.000677	CcSEcCtD
Ofloxacin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.000145	0.000676	CcSEcCtD
Ofloxacin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.000144	0.000673	CcSEcCtD
Ofloxacin—Paraesthesia—Carmustine—lymphatic system cancer	0.000144	0.000673	CcSEcCtD
Ofloxacin—Mood swings—Methotrexate—lymphatic system cancer	0.000143	0.000669	CcSEcCtD
Ofloxacin—Hypotension—Vincristine—lymphatic system cancer	0.000143	0.000668	CcSEcCtD
Ofloxacin—Dyspnoea—Carmustine—lymphatic system cancer	0.000143	0.000668	CcSEcCtD
Ofloxacin—Somnolence—Carmustine—lymphatic system cancer	0.000143	0.000666	CcSEcCtD
Ofloxacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000142	0.000664	CcSEcCtD
Ofloxacin—Ataxia—Methotrexate—lymphatic system cancer	0.000142	0.000664	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.000139	0.000651	CcSEcCtD
Ofloxacin—Decreased appetite—Carmustine—lymphatic system cancer	0.000139	0.000651	CcSEcCtD
Ofloxacin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000139	0.000651	CcSEcCtD
Ofloxacin—Insomnia—Vincristine—lymphatic system cancer	0.000138	0.000647	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.000138	0.000647	CcSEcCtD
Ofloxacin—Paraesthesia—Vincristine—lymphatic system cancer	0.000137	0.000642	CcSEcCtD
Ofloxacin—Constipation—Carmustine—lymphatic system cancer	0.000137	0.000641	CcSEcCtD
Ofloxacin—Pain—Carmustine—lymphatic system cancer	0.000137	0.000641	CcSEcCtD
Ofloxacin—Breast disorder—Methotrexate—lymphatic system cancer	0.000137	0.000638	CcSEcCtD
Ofloxacin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000136	0.000636	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.000136	0.000634	CcSEcCtD
Ofloxacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000135	0.000632	CcSEcCtD
Ofloxacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000134	0.000625	CcSEcCtD
Ofloxacin—Decreased appetite—Vincristine—lymphatic system cancer	0.000133	0.000622	CcSEcCtD
Ofloxacin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000133	0.000621	CcSEcCtD
Ofloxacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000133	0.000619	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.000132	0.000617	CcSEcCtD
Ofloxacin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000132	0.000617	CcSEcCtD
Ofloxacin—Fatigue—Vincristine—lymphatic system cancer	0.000132	0.000616	CcSEcCtD
Ofloxacin—Asthenia—Bleomycin—lymphatic system cancer	0.000132	0.000616	CcSEcCtD
Ofloxacin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.000131	0.000613	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.000131	0.000612	CcSEcCtD
Ofloxacin—Pain—Vincristine—lymphatic system cancer	0.000131	0.000611	CcSEcCtD
Ofloxacin—Constipation—Vincristine—lymphatic system cancer	0.000131	0.000611	CcSEcCtD
Ofloxacin—Asthma—Methotrexate—lymphatic system cancer	0.000131	0.00061	CcSEcCtD
Ofloxacin—Pruritus—Bleomycin—lymphatic system cancer	0.00013	0.000607	CcSEcCtD
Ofloxacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00013	0.000605	CcSEcCtD
Ofloxacin—Eosinophilia—Methotrexate—lymphatic system cancer	0.000129	0.000604	CcSEcCtD
Ofloxacin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000129	0.0006	CcSEcCtD
Ofloxacin—Pancreatitis—Methotrexate—lymphatic system cancer	0.000128	0.000598	CcSEcCtD
Ofloxacin—Pain—Mitoxantrone—lymphatic system cancer	0.000127	0.000595	CcSEcCtD
Ofloxacin—Constipation—Mitoxantrone—lymphatic system cancer	0.000127	0.000595	CcSEcCtD
Ofloxacin—Body temperature increased—Carmustine—lymphatic system cancer	0.000127	0.000592	CcSEcCtD
Ofloxacin—Abdominal pain—Carmustine—lymphatic system cancer	0.000127	0.000592	CcSEcCtD
Ofloxacin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000125	0.000585	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000125	0.000585	CcSEcCtD
Ofloxacin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000124	0.000579	CcSEcCtD
Ofloxacin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000123	0.000574	CcSEcCtD
Ofloxacin—Dysuria—Methotrexate—lymphatic system cancer	0.000122	0.00057	CcSEcCtD
Ofloxacin—Neutropenia—Methotrexate—lymphatic system cancer	0.000122	0.00057	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000122	0.000569	CcSEcCtD
Ofloxacin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.000121	0.000567	CcSEcCtD
Ofloxacin—Abdominal pain—Vincristine—lymphatic system cancer	0.000121	0.000565	CcSEcCtD
Ofloxacin—Body temperature increased—Vincristine—lymphatic system cancer	0.000121	0.000565	CcSEcCtD
Ofloxacin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00012	0.000562	CcSEcCtD
Ofloxacin—Photosensitivity reaction—Methotrexate—lymphatic system cancer	0.000119	0.000557	CcSEcCtD
Ofloxacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000118	0.000553	CcSEcCtD
Ofloxacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.000118	0.000552	CcSEcCtD
Ofloxacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.000118	0.00055	CcSEcCtD
Ofloxacin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.000118	0.00055	CcSEcCtD
Ofloxacin—Pneumonia—Methotrexate—lymphatic system cancer	0.000117	0.000547	CcSEcCtD
Ofloxacin—Vomiting—Bleomycin—lymphatic system cancer	0.000117	0.000546	CcSEcCtD
Ofloxacin—Infestation NOS—Methotrexate—lymphatic system cancer	0.000116	0.000544	CcSEcCtD
Ofloxacin—Infestation—Methotrexate—lymphatic system cancer	0.000116	0.000544	CcSEcCtD
Ofloxacin—Drowsiness—Methotrexate—lymphatic system cancer	0.000116	0.000544	CcSEcCtD
Ofloxacin—Rash—Bleomycin—lymphatic system cancer	0.000116	0.000541	CcSEcCtD
Ofloxacin—Dermatitis—Bleomycin—lymphatic system cancer	0.000116	0.000541	CcSEcCtD
Ofloxacin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000115	0.000539	CcSEcCtD
Ofloxacin—Asthenia—Carmustine—lymphatic system cancer	0.000115	0.000537	CcSEcCtD
Ofloxacin—Renal failure—Methotrexate—lymphatic system cancer	0.000114	0.000535	CcSEcCtD
Ofloxacin—Stomatitis—Methotrexate—lymphatic system cancer	0.000113	0.00053	CcSEcCtD
Ofloxacin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.000113	0.000529	CcSEcCtD
Ofloxacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000113	0.000527	CcSEcCtD
Ofloxacin—Haematuria—Methotrexate—lymphatic system cancer	0.000111	0.000519	CcSEcCtD
Ofloxacin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00011	0.000514	CcSEcCtD
Ofloxacin—Epistaxis—Methotrexate—lymphatic system cancer	0.00011	0.000513	CcSEcCtD
Ofloxacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00011	0.000513	CcSEcCtD
Ofloxacin—Asthenia—Vincristine—lymphatic system cancer	0.00011	0.000513	CcSEcCtD
Ofloxacin—Diarrhoea—Carmustine—lymphatic system cancer	0.00011	0.000512	CcSEcCtD
Ofloxacin—Nausea—Bleomycin—lymphatic system cancer	0.000109	0.00051	CcSEcCtD
Ofloxacin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000109	0.000508	CcSEcCtD
Ofloxacin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000107	0.0005	CcSEcCtD
Ofloxacin—Dizziness—Carmustine—lymphatic system cancer	0.000106	0.000495	CcSEcCtD
Ofloxacin—Haemoglobin—Methotrexate—lymphatic system cancer	0.000105	0.000491	CcSEcCtD
Ofloxacin—Diarrhoea—Vincristine—lymphatic system cancer	0.000105	0.000489	CcSEcCtD
Ofloxacin—Haemorrhage—Methotrexate—lymphatic system cancer	0.000105	0.000488	CcSEcCtD
Ofloxacin—Hepatitis—Methotrexate—lymphatic system cancer	0.000105	0.000488	CcSEcCtD
Ofloxacin—Pharyngitis—Methotrexate—lymphatic system cancer	0.000104	0.000485	CcSEcCtD
Ofloxacin—Urinary tract disorder—Methotrexate—lymphatic system cancer	0.000103	0.000482	CcSEcCtD
Ofloxacin—Urethral disorder—Methotrexate—lymphatic system cancer	0.000102	0.000479	CcSEcCtD
Ofloxacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000102	0.000476	CcSEcCtD
Ofloxacin—Vomiting—Carmustine—lymphatic system cancer	0.000102	0.000476	CcSEcCtD
Ofloxacin—Dizziness—Vincristine—lymphatic system cancer	0.000101	0.000473	CcSEcCtD
Ofloxacin—Rash—Carmustine—lymphatic system cancer	0.000101	0.000472	CcSEcCtD
Ofloxacin—Dermatitis—Carmustine—lymphatic system cancer	0.000101	0.000472	CcSEcCtD
Ofloxacin—Visual impairment—Methotrexate—lymphatic system cancer	0.000101	0.000471	CcSEcCtD
Ofloxacin—Headache—Carmustine—lymphatic system cancer	0.0001	0.000469	CcSEcCtD
Ofloxacin—Erythema multiforme—Methotrexate—lymphatic system cancer	9.88e-05	0.000462	CcSEcCtD
Ofloxacin—Eye disorder—Methotrexate—lymphatic system cancer	9.77e-05	0.000456	CcSEcCtD
Ofloxacin—Tinnitus—Methotrexate—lymphatic system cancer	9.75e-05	0.000455	CcSEcCtD
Ofloxacin—Vomiting—Vincristine—lymphatic system cancer	9.73e-05	0.000455	CcSEcCtD
Ofloxacin—Cardiac disorder—Methotrexate—lymphatic system cancer	9.7e-05	0.000453	CcSEcCtD
Ofloxacin—Rash—Vincristine—lymphatic system cancer	9.65e-05	0.000451	CcSEcCtD
Ofloxacin—Dermatitis—Vincristine—lymphatic system cancer	9.64e-05	0.00045	CcSEcCtD
Ofloxacin—Headache—Vincristine—lymphatic system cancer	9.59e-05	0.000448	CcSEcCtD
Ofloxacin—Nausea—Carmustine—lymphatic system cancer	9.52e-05	0.000445	CcSEcCtD
Ofloxacin—Angiopathy—Methotrexate—lymphatic system cancer	9.48e-05	0.000443	CcSEcCtD
Ofloxacin—Vomiting—Mitoxantrone—lymphatic system cancer	9.48e-05	0.000443	CcSEcCtD
Ofloxacin—Immune system disorder—Methotrexate—lymphatic system cancer	9.44e-05	0.000441	CcSEcCtD
Ofloxacin—Mediastinal disorder—Methotrexate—lymphatic system cancer	9.42e-05	0.00044	CcSEcCtD
Ofloxacin—Rash—Mitoxantrone—lymphatic system cancer	9.4e-05	0.000439	CcSEcCtD
Ofloxacin—Dermatitis—Mitoxantrone—lymphatic system cancer	9.39e-05	0.000439	CcSEcCtD
Ofloxacin—Chills—Methotrexate—lymphatic system cancer	9.38e-05	0.000438	CcSEcCtD
Ofloxacin—Headache—Mitoxantrone—lymphatic system cancer	9.34e-05	0.000436	CcSEcCtD
Ofloxacin—Alopecia—Methotrexate—lymphatic system cancer	9.24e-05	0.000432	CcSEcCtD
Ofloxacin—Mental disorder—Methotrexate—lymphatic system cancer	9.16e-05	0.000428	CcSEcCtD
Ofloxacin—Malnutrition—Methotrexate—lymphatic system cancer	9.1e-05	0.000425	CcSEcCtD
Ofloxacin—Erythema—Methotrexate—lymphatic system cancer	9.1e-05	0.000425	CcSEcCtD
Ofloxacin—Nausea—Vincristine—lymphatic system cancer	9.09e-05	0.000425	CcSEcCtD
Ofloxacin—Dysgeusia—Methotrexate—lymphatic system cancer	8.91e-05	0.000416	CcSEcCtD
Ofloxacin—Nausea—Mitoxantrone—lymphatic system cancer	8.85e-05	0.000414	CcSEcCtD
Ofloxacin—Back pain—Methotrexate—lymphatic system cancer	8.8e-05	0.000411	CcSEcCtD
Ofloxacin—Vision blurred—Methotrexate—lymphatic system cancer	8.58e-05	0.000401	CcSEcCtD
Ofloxacin—Ill-defined disorder—Methotrexate—lymphatic system cancer	8.44e-05	0.000394	CcSEcCtD
Ofloxacin—Anaemia—Methotrexate—lymphatic system cancer	8.41e-05	0.000393	CcSEcCtD
Ofloxacin—Malaise—Methotrexate—lymphatic system cancer	8.21e-05	0.000383	CcSEcCtD
Ofloxacin—Vertigo—Methotrexate—lymphatic system cancer	8.18e-05	0.000382	CcSEcCtD
Ofloxacin—Leukopenia—Methotrexate—lymphatic system cancer	8.14e-05	0.000381	CcSEcCtD
Ofloxacin—Cough—Methotrexate—lymphatic system cancer	7.94e-05	0.000371	CcSEcCtD
Ofloxacin—Myalgia—Methotrexate—lymphatic system cancer	7.75e-05	0.000362	CcSEcCtD
Ofloxacin—Chest pain—Methotrexate—lymphatic system cancer	7.75e-05	0.000362	CcSEcCtD
Ofloxacin—Arthralgia—Methotrexate—lymphatic system cancer	7.75e-05	0.000362	CcSEcCtD
Ofloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	7.69e-05	0.000359	CcSEcCtD
Ofloxacin—Discomfort—Methotrexate—lymphatic system cancer	7.65e-05	0.000358	CcSEcCtD
Ofloxacin—Confusional state—Methotrexate—lymphatic system cancer	7.49e-05	0.00035	CcSEcCtD
Ofloxacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	7.43e-05	0.000347	CcSEcCtD
Ofloxacin—Infection—Methotrexate—lymphatic system cancer	7.38e-05	0.000345	CcSEcCtD
Ofloxacin—Nervous system disorder—Methotrexate—lymphatic system cancer	7.28e-05	0.00034	CcSEcCtD
Ofloxacin—Thrombocytopenia—Methotrexate—lymphatic system cancer	7.27e-05	0.00034	CcSEcCtD
Ofloxacin—Skin disorder—Methotrexate—lymphatic system cancer	7.21e-05	0.000337	CcSEcCtD
Ofloxacin—Hyperhidrosis—Methotrexate—lymphatic system cancer	7.18e-05	0.000335	CcSEcCtD
Ofloxacin—Anorexia—Methotrexate—lymphatic system cancer	7.08e-05	0.000331	CcSEcCtD
Ofloxacin—Hypotension—Methotrexate—lymphatic system cancer	6.94e-05	0.000324	CcSEcCtD
Ofloxacin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	6.77e-05	0.000316	CcSEcCtD
Ofloxacin—Insomnia—Methotrexate—lymphatic system cancer	6.72e-05	0.000314	CcSEcCtD
Ofloxacin—Paraesthesia—Methotrexate—lymphatic system cancer	6.67e-05	0.000312	CcSEcCtD
Ofloxacin—Dyspnoea—Methotrexate—lymphatic system cancer	6.62e-05	0.000309	CcSEcCtD
Ofloxacin—Somnolence—Methotrexate—lymphatic system cancer	6.6e-05	0.000308	CcSEcCtD
Ofloxacin—Dyspepsia—Methotrexate—lymphatic system cancer	6.54e-05	0.000305	CcSEcCtD
Ofloxacin—Decreased appetite—Methotrexate—lymphatic system cancer	6.46e-05	0.000302	CcSEcCtD
Ofloxacin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	6.41e-05	0.0003	CcSEcCtD
Ofloxacin—Fatigue—Methotrexate—lymphatic system cancer	6.4e-05	0.000299	CcSEcCtD
Ofloxacin—Pain—Methotrexate—lymphatic system cancer	6.35e-05	0.000297	CcSEcCtD
Ofloxacin—Feeling abnormal—Methotrexate—lymphatic system cancer	6.12e-05	0.000286	CcSEcCtD
Ofloxacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	6.07e-05	0.000284	CcSEcCtD
Ofloxacin—Urticaria—Methotrexate—lymphatic system cancer	5.9e-05	0.000276	CcSEcCtD
Ofloxacin—Abdominal pain—Methotrexate—lymphatic system cancer	5.87e-05	0.000274	CcSEcCtD
Ofloxacin—Body temperature increased—Methotrexate—lymphatic system cancer	5.87e-05	0.000274	CcSEcCtD
Ofloxacin—Hypersensitivity—Methotrexate—lymphatic system cancer	5.47e-05	0.000256	CcSEcCtD
Ofloxacin—Asthenia—Methotrexate—lymphatic system cancer	5.33e-05	0.000249	CcSEcCtD
Ofloxacin—Pruritus—Methotrexate—lymphatic system cancer	5.25e-05	0.000245	CcSEcCtD
Ofloxacin—Diarrhoea—Methotrexate—lymphatic system cancer	5.08e-05	0.000237	CcSEcCtD
Ofloxacin—Dizziness—Methotrexate—lymphatic system cancer	4.91e-05	0.000229	CcSEcCtD
Ofloxacin—Vomiting—Methotrexate—lymphatic system cancer	4.72e-05	0.000221	CcSEcCtD
Ofloxacin—Rash—Methotrexate—lymphatic system cancer	4.68e-05	0.000219	CcSEcCtD
Ofloxacin—Dermatitis—Methotrexate—lymphatic system cancer	4.68e-05	0.000219	CcSEcCtD
Ofloxacin—Headache—Methotrexate—lymphatic system cancer	4.65e-05	0.000217	CcSEcCtD
Ofloxacin—Nausea—Methotrexate—lymphatic system cancer	4.41e-05	0.000206	CcSEcCtD
